Diffusion- and Tractography-Based Characterization of Tissue Damage Within and Surrounding Paramagnetic Rim Lesions in Multiple Sclerosis

References

1. 1.↵
   1. Nylander A,
   2. Hafler DA

   . Multiple sclerosis. J Clin Invest 2012;122:1180–88 doi:10.1172/JCI58649 pmid:22466660

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Compston A,
   2. Coles A

   . Multiple sclerosis. Lancet 2008;372:1502–17 doi:10.1016/S0140-6736(08)61620-7 pmid:18970977

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Frohman EM,
   2. Racke MK,
   3. Raine CS

   . Multiple sclerosis—the plaque and its pathogenesis. N Engl J Med 2006;354:942–55 doi:10.1056/NEJMra052130 pmid:16510748

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Kuhlmann T,
   2. Ludwin S,
   3. Prat A, et al

   . An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol 2017;133:13–24 doi:10.1007/s00401-016-1653-y

   CrossRefPubMed
5. 5.↵
   1. Calvi A,
   2. Haider L,
   3. Prados F, et al

   . In vivo imaging of chronic active lesions in multiple sclerosis. Mult Scler 2022;28:683–90 doi:10.1177/1352458520958589 pmid:32965168

   CrossRefPubMed
6. 6.↵
   1. Siger M

   . Magnetic resonance imaging in primary progressive multiple sclerosis patients: review. Clin Neuroradiol 2022;32:625–41 doi:10.1007/s00062-022-01144-3 pmid:35258820

   CrossRefPubMed
7. 7.↵
   1. Filippi M,
   2. Preziosa P,
   3. Barkhof F, et al

   . Diagnosis of progressive multiple sclerosis from the imaging perspective: a review. JAMA Neurol 2021;78:351–64 doi:10.1001/jamaneurol.2020.4689 pmid:33315071

   CrossRefPubMed
8. 8.↵
   1. Bagnato F,
   2. Sati P,
   3. Hemond CC, et al

   . Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain 2024;147:213–33 doi:10.1093/brain/awae013

   CrossRefPubMed
9. 9.↵
   1. Absinta M,
   2. Sati P,
   3. Masuzzo F, et al

   . Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol 2019;76:1474–83 doi:10.1001/jamaneurol.2019.2399 pmid:31403674

   CrossRefPubMed
10. 10.↵
    1. Ng Kee Kwong KC,
    2. Mollison D,
    3. Meijboom R, et al

    . The prevalence of paramagnetic rim lesions in multiple sclerosis: a systematic review and meta-analysis. PLoS One 2021;16:e0256845 doi:10.1371/journal.pone.0256845

    CrossRefPubMed
11. 11.↵
    1. Reeves JA,
    2. Weinstock Z,
    3. Zivadinov R, et al

    . Paramagnetic rim lesions are associated with greater incidence of relapse and worse cognitive recovery following relapse. Mult Scler 2023;29:1033–38 doi:10.1177/13524585231169466 pmid:37161349

    CrossRefPubMed
12. 12.↵
    1. Dal-Bianco A,
    2. Grabner G,
    3. Kronnerwetter C, et al

    . Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol 2017;133:25–42 doi:10.1007/s00401-016-1636-z

    CrossRefPubMed
13. 13.↵
    1. Jakimovski D,
    2. Gandhi S,
    3. Paunkoski I, et al

    . Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5‐year longitudinal study. Euro J Neuro 2019;26:87 doi:10.1111/ene.13769 pmid:30103277

    CrossRefPubMed
14. 14.↵
    1. Zhou D,
    2. Liu T,
    3. Spincemaille P, et al

    . Background field removal by solving the Laplacian boundary value problem. NMR Biomed 2014;27:312–19 doi:10.1002/nbm.3064 pmid:24395595

    CrossRefPubMed
15. 15.↵
    1. Schweser F,
    2. Deistung A,
    3. Sommer K, et al

    . Toward online reconstruction of quantitative susceptibility maps: superfast dipole inversion. Magn Reson Med 2013;69:1582–94 pmid:22791625

    CrossRefPubMed
16. 16.↵
    1. Zivadinov R,
    2. Rudick RA,
    3. De Masi R, et al

    . Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001;57:1239–47 doi:10.1212/wnl.57.7.1239 pmid:11591843

    Abstract/FREE Full Text
17. 17.↵
    1. Reeves JA,
    2. Mohebbi M,
    3. Zivadinov R, et al

    . Reliability of paramagnetic rim lesion classification on quantitative susceptibility mapping (QSM) in people with multiple sclerosis: single-site experience and systematic review. Mult Scler Relat Disord 2023;79:104968 doi:10.1016/j.msard.2023.104968

    CrossRefPubMed
18. 18.↵
    1. Schilling KG,
    2. Blaber J,
    3. Hansen C, et al

    . Distortion correction of diffusion weighted MRI without reverse phase-encoding scans or field-maps. PLoS ONE 2020;15:e0236418 doi:10.1371/journal.pone.0236418 pmid:32735601

    CrossRefPubMed
19. 19.↵
    1. Schilling KG,
    2. Blaber J,
    3. Huo Y, et al

    . Synthesized b0 for diffusion distortion correction (Synb0-DisCo). Magn Reson Imaging 2019;64:62–70 doi:10.1016/j.MRI.2019.05.008

    CrossRefPubMed
20. 20.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Woolrich MW, et al

    . Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004;23 Suppl 1:S208–19 doi:10.1016/j.neuroimage.2004.07.051

    CrossRefPubMed
21. 21.↵
    1. Andersson JLR,
    2. Skare S,
    3. Ashburner J

    . How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. NeuroImage 2003;20:870–88 doi:10.1016/S1053-8119(03)00336-7

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Andersson JLR,
    2. Sotiropoulos SN

    . An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. NeuroImage 2016;125:1063–78 doi:10.1016/j.neuroimage.2015.10.019 pmid:26481672

    CrossRefPubMed
23. 23.↵
    1. Yeh F-C,
    2. Wedeen VJ,
    3. Tseng WYI

    . Generalized q-sampling imaging. IEEE Trans Med Imaging 2010;29:1626–35 doi:10.1109/TMI.2010.2045126 pmid:20304721

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Detobel J

    . Microstructural Analysis of Paramagnetic Rim Lesions in Multiple Sclerosis Using Diffusion Weighted Magnetic Resonance Imaging. Master’s thesis. Ecole Polytechnique de Louvain, Université Catholique de Louvain; 2022. http://hdl.handle.net/2078.1/thesis:37900
25. 25.↵
    1. Shi Z,
    2. Pan Y,
    3. Yan Z, et al

    . Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging. Mult Scler Relat Disord 2023;71:104572 doi:10.1016/j.msard.2023.104572 pmid:36821979

    CrossRefPubMed
26. 26.↵
    1. Hu H,
    2. Ye L,
    3. Ding S, et al

    . The heterogeneity of tissue destruction between iron rim lesions and non-iron rim lesions in multiple sclerosis: a diffusion MRI study. Mult Scler Relat Disord 2022;66:104070 doi:10.1016/j.msard.2022.104070 pmid:35914471

    CrossRefPubMed
27. 27.↵
    1. Yeh FC,
    2. Verstynen TD,
    3. Wang Y, et al

    . Deterministic diffusion fiber tracking improved by quantitative anisotropy. PLoS ONE 2013;8:e80713 doi:10.1371/journal.pone.0080713 pmid:24348913

    CrossRefPubMed
28. 28.↵
    1. Yeh F,
    2. Liu L,
    3. Hitchens TK, et al

    . Mapping immune cell infiltration using restricted diffusion MRI. Magn Reson Med 2017;77:603–12 doi:10.1002/mrm.26143

    CrossRefPubMed
29. 29.↵
    1. Maggi P,
    2. Kuhle J,
    3. Schädelin S, et al

    . Chronic white matter inflammation and serum neurofilament levels in multiple sclerosis. Neurology 2021;97:e543–53 doi:10.1212/WNL.0000000000012326 pmid:34088875

    Abstract/FREE Full Text
30. 30.↵
    1. Zhang J,
    2. Tao R,
    3. Liu C, et al

    . Possible effects of iron deposition on the measurement of DTI metrics in deep gray matter nuclei: an in vitro and in vivo study. Neuroscience Letters 2013;551:47–52 doi:10.1016/j.neulet.2013.07.003

    CrossRefPubMed
31. 31.↵
    1. Yeh FC,
    2. Zaydan IM,
    3. Suski VR, et al

    . Differential tractography as a track-based biomarker for neuronal injury. NeuroImage 2019;202:116131 doi:10.1016/j.neuroimage.2019.116131

    CrossRefPubMed